Zacks.com on MSN11h
Elite Pharmaceuticals' Stock Up Despite Q2 Earnings DeclineShares of Elite Pharmaceuticals, Inc. ELTP have gained 12.2% since the company released its earnings for the quarter ended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback